An antibody that recognizes the protein FGFR4 delivers anticancer drugs directly to cancer cells, slowing or stopping tumor growth in mice.
An antibody that recognizes the protein FGFR4 delivers anticancer drugs directly to cancer cells, slowing or stopping tumor growth in mice.